CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $2.68M invested in Chemomab Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
83% less capital invested
Capital invested by funds: $15.9M → $2.68M (-$13.2M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$41K | |
| 2 | +$21K | |
| 3 | +$5.11K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.87K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.19K |
Top Sellers
| 1 | -$134K | |
| 2 | -$4K | |
| 3 | -$4K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$48 |